European Recovery Drives Up BioGaia's Sales
Executive Summary
Swedish probiotics manufacturer BioGaia saw its sales rise by almost 50% in Q2 as the end to COVID-19 restrictions in Europe allowed it to reach consumers in doctor's offices and pharmacies. CEO Isabelle Ducellier is confident that despite the squeeze on disposable incomes by the worsening macroeconomic situation the global demand for probiotics will continue.